tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) Technical Analysis

939 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Karyopharm Therapeutics’s (KPTI) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Karyopharm Therapeutics is a Sell.
Karyopharm Therapeutics’s (KPTI) 20-Day exponential moving average is 0.80, while Karyopharm Therapeutics’s (KPTI) share price is $0.86, making it a Buy.
Karyopharm Therapeutics’s (KPTI) 50-Day exponential moving average is 0.93, while Karyopharm Therapeutics’s (KPTI) share price is $0.86, making it a Sell.

Karyopharm Therapeutics (KPTI) Pivot Points

Dec 10, 2023, 12:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.75
0.79
0.82
0.85
0.88
0.92
0.94
Fibonacci
0.79
0.82
0.83
0.85
0.88
0.89
0.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Karyopharm Therapeutics (KPTI) Moving Averages

Dec 10, 2023, 12:59 PM
Period
Simple
Exponential
MA5
0.85Buy
0.84Buy
MA10
0.79Buy
0.81Buy
MA20
0.76Buy
0.80Buy
MA50
0.93Sell
0.93Sell
MA100
1.20Sell
1.23Sell
MA200
2.02Sell
1.93Sell
Karyopharm Therapeutics’s (KPTI) 10-Day exponential moving average is 0.81, while Karyopharm Therapeutics’s (KPTI) share price is $0.86, making it a Buy.
Karyopharm Therapeutics’s (KPTI) 100-Day exponential moving average is 1.23, while Karyopharm Therapeutics’s (KPTI) share price is $0.86, making it a Sell.
Karyopharm Therapeutics’s (KPTI) stock price is $0.86 and Karyopharm Therapeutics’s (KPTI) 50-day simple moving average is 0.93, creating a Sell signal.
Karyopharm Therapeutics’s (KPTI) stock price is $0.86 and Karyopharm Therapeutics’s (KPTI) 100-day simple moving average is 1.20, creating a Sell signal.
Karyopharm Therapeutics’s (KPTI) stock price is $0.86 and Karyopharm Therapeutics’s (KPTI) 200-day simple moving average is 2.02, creating a Sell signal.

Karyopharm Therapeutics (KPTI) Technical Indicators

Dec 10, 2023, 12:59 PM
Name
Value
Implied Action
RSI (14)
53.49
Neutral
STOCH (9,6)
81.08
Sell
STOCHRSI (14)
81.08
Sell
MACD (12,26)
0.02
Sell
ADX (14)
20.38
Neutral
Williams %R
14.80
Sell
CCI (14)
136.25
Sell
ATR (14)
0.08
-
Ultimate Oscillator
51.74
Neutral
ROC
10.26
Buy
Karyopharm Therapeutics’s (KPTI) Relative Strength Index (RSI) is 53.49, creating a Neutral signal.
Karyopharm Therapeutics’s (KPTI) Trend Strength Indicator (ADX) is 20.38, creating a Neutral signal.
Karyopharm Therapeutics’s (KPTI) Commodity Channel Index (CCI) is 136.25, creating a Sell signal.
Karyopharm Therapeutics’s (KPTI) Price Rate of Change (ROC) is 10.26, creating a Buy signal.

FAQ

Is KPTI a Buy, Hold, or Sell?
Based on KPTI’s technical indicators, KPTI is a Sell.
    What is KPTI’s RSI (14)?
    KPTI’s RSI (14) is 53.49, which suggests KPTI is a Neutral.
      What is KPTI’s MACD?
      KPTI’s MACD is -0.02, which suggests KPTI is a Sell.
        What is KPTI’s 5-day moving average?
        KPTI’s 5-day moving average is 0.85, which suggests KPTI is a Buy.
          What is KPTI’s 20-day moving average?
          KPTI 20-day moving average is 0.76, which suggests KPTI is a Buy.
            What is KPTI’s 50-day moving average?
            KPTI’s 50-day moving average is 0.93, which suggests KPTI is a Sell.
              What is KPTI’s 200-day moving average?
              KPTI’s 200-day moving average is 2.02, which suggests KPTI is a Sell.
                What is KPTI’s Williams % R (14)?
                KPTI’s Williams % R (14) is -14.80, which suggests KPTI is a Sell.
                  What is KPTI’s CCI (14)?
                  KPTI’s CCI (14) is 136.25, which suggests KPTI is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis